DOSING REGIMEN FOR THE USE OF SIPONIMOD FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME

摘要

Provided is a dosing regimen for the administration of siponimod, or a pharmaceutically acceptable salt, co-crystal, hydrate, solvate, polymorph and/or mixtures thereof for treating respiratory distress syndrome (ARDS) resulting from infections that causes ARDS, such as viral infections, bacterial infections and fungal infections. In particular, the dosing regimen is for use in the treatment of ARDS from coronavirus (SARS-CoV) infections in corona virus disease patients, in particular SARS-CoV-2 infections in coronavirus disease 2019 (COVID-19) patients.